Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): Structure–activity relationships and strategies for the elimination of reactive metabolite formation
Daniel P. Walker, F. Christopher Bi, Amit S. Kalgutkar, Jonathan N. Bauman, Sabrina X. Zhao, John R. Soglia, Gary E. Aspnes, Daniel W. Kung, Jacquelyn Klug-McLeod, Michael P. Zawistoski, Molly A. McGlVolume:
18
Year:
2008
Language:
english
Pages:
7
DOI:
10.1016/j.bmcl.2008.10.030
File:
PDF, 345 KB
english, 2008